Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
FBLG
FBLG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest FBLG ETF News Today | Earnings, Events & Price Alerts
FBLG News
FibroBiologics Shares Surge 22% After New Patent Grant for Osteoporosis Treatment
2d ago
NASDAQ.COM
Avaí Bio Advances Cell Therapy Production Milestone
1d ago
PRnewswire
Avaí Bio Advances α-Klotho Cell Production Milestone
1d ago
Newsfilter
FibroBiologics Secures New Patent for Osteoporosis Treatment
2d ago
Newsfilter
FibroBiologics Reports Increased Losses for 2025 Fiscal Year
Feb 24 2026
seekingalpha
FibroBiologics Initiates Clinical Trial Plans for Diabetic Foot Ulcers
Feb 24 2026
Newsfilter
FibroBiologics Secures Nasdaq Compliance Extension
Feb 23 2026
seekingalpha
FibroBiologics Secures Nasdaq Compliance Extension
Feb 23 2026
Newsfilter
FibroBiologics Secures Canadian Patent for Cachexia Treatment
Feb 05 2026
Newsfilter
Align Technology Reports Strong Q4 Earnings Beat
Feb 05 2026
Benzinga
FibroBiologics CEO Pete O'Heeron to Present at DealFlow Discovery Conference on January 29, 2026
Jan 20 2026
Newsfilter
FibroBiologics (FBLG) Stock Rises 7.68%, Attracts Market Attention
Jan 13 2026
NASDAQ.COM
FibroBiologics Files IND for CYPS317 Clinical Trials Targeting Psoriasis
Dec 31 2025
Globenewswire
FibroBiologics Files IND for CYPS317 Clinical Trials Targeting Psoriasis
Dec 31 2025
Newsfilter
FibroBiologics Closes $1.7 Million Registered Direct Offering
Dec 16 2025
Globenewswire
FibroBiologics Closes $1.7 Million Registered Direct Offering
Dec 16 2025
Newsfilter
Show More News
